Robert J Bitterman insider trades

Open-market stock purchases and sales by Robert J Bitterman, Chairman, Pres. & CEO at Phio Pharmaceuticals Corp, from SEC Form 4 filings since Jun 7, 2013.

Track record: 33% of 21 scored buys are up 5% or more since purchase, averaging +0%.

Recent trades

DateStockTradeValue
Sep 28, 2026PHIO Phio Pharmaceuticals CorpBought (not open market)—
Sep 22, 2026PHIO Phio Pharmaceuticals CorpBought$2.1K
Sep 11, 2026PHIO Phio Pharmaceuticals CorpSold (not open market)$70.6K
Aug 18, 2026PHIO Phio Pharmaceuticals CorpBought$10.6K
Jun 26, 2026PHIO Phio Pharmaceuticals CorpBought$9.9K
Feb 5, 2026PHIO Phio Pharmaceuticals CorpBought (not open market)—
Dec 31, 2025PHIO Phio Pharmaceuticals CorpBought$5.2K
Dec 23, 2025PHIO Phio Pharmaceuticals CorpBought$5.1K
Nov 21, 2025PHIO Phio Pharmaceuticals CorpBought$5.7K
Nov 18, 2025PHIO Phio Pharmaceuticals CorpBought$6.3K

Companies traded

  • PHIO Phio Pharmaceuticals Corp: 22 buys, last Sep 28, 2026
  • RXII RXi Pharmaceuticals Corp: 6 buys, last Aug 1, 2018

Get free alerts when Robert J Bitterman files a new trade →